Nicola R Sibson Selected Research

Nicola R Sibson Research Topics

Disease

17	Neoplasm Metastasis (Metastasis) 04/2023 - 04/2012
16	Neoplasms (Cancer) 01/2022 - 04/2012
10	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2012
10	Inflammation (Inflammations) 01/2022 - 02/2004
8	Multiple Sclerosis 09/2015 - 11/2002
4	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2016
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2015 - 04/2009
4	Encephalitis (Encephalitis, Rasmussen) 01/2011 - 11/2002
3	Neoplasm Micrometastasis 01/2022 - 04/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 06/2010
3	Neuroinflammatory Diseases 01/2020 - 05/2014
3	Hypersensitivity (Allergy) 09/2014 - 04/2009
3	Cerebral Malaria 01/2011 - 11/2002
2	Hypoxia (Hypoxemia) 01/2021 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2015
2	Stroke (Strokes) 11/2019 - 01/2017
2	Disease Progression 06/2014 - 06/2004
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2014 - 05/2014
2	Brain Ischemia (Cerebral Ischemia) 01/2011 - 06/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Cognitive Dysfunction 01/2021
1	Ischemic Stroke 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Relapsing-Remitting Multiple Sclerosis 12/2017
1	Neuromyelitis Optica (Devic's Disease) 12/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Hypercapnia 01/2017
1	Alkalosis 11/2016
1	Glioma (Gliomas) 01/2016
1	Chronic Progressive Multiple Sclerosis 10/2014
1	Demyelinating Diseases (Demyelinating Disease) 04/2014
1	Chronic Disease (Chronic Diseases) 04/2014
1	Carcinoma (Carcinomatosis) 02/2014

Drug/Important Bio-Agent (IBA)

9	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022 - 10/2007
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
6	GadoliniumIBA 01/2020 - 12/2011
6	LigandsIBA 11/2019 - 10/2007
5	ferric oxide (iron oxide)IBA 01/2020 - 10/2007
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2014
4	Contrast MediaIBA 11/2016 - 02/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2002
3	CytokinesIBA 05/2013 - 03/2008
2	SynucleinsIBA 02/2024 - 11/2011
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 11/2013
2	APTIBA 01/2021 - 01/2019
2	AmidesIBA 01/2021 - 01/2019
2	Protons (Proton)IBA 01/2021 - 01/2019
2	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2021 - 04/2014
2	AntibodiesIBA 11/2019 - 12/2017
2	Myelin-Oligodendrocyte GlycoproteinIBA 12/2017 - 04/2009
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2016 - 04/2014
2	Serotonin (5 Hydroxytryptamine)IBA 07/2014 - 01/2013
2	Integrin alpha4beta1 (VLA-4)IBA 04/2014 - 10/2007
2	Messenger RNA (mRNA)IBA 06/2013 - 11/2011
2	LipopolysaccharidesIBA 01/2013 - 11/2011
1	IronIBA 04/2023
1	Gadolinium DTPA (Magnevist)FDA Link 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	pimonidazoleIBA 01/2021
1	fluoromisonidazoleIBA 01/2021
1	alovudineIBA 01/2021
1	Ciliary Neurotrophic Factor (CNTF)IBA 12/2020
1	WP1066IBA 12/2020
1	Arginine (L-Arginine)FDA Link 11/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2019
1	VitronectinIBA 11/2019
1	Aspartic Acid (Aspartate)FDA Link 11/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Radioisotopes (Radionuclides)IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Vasodilator Agents (Vasodilators)IBA 01/2017
1	CalciumIBA 01/2017
1	Clodronic Acid (Clodronate)IBA 01/2017
1	Bovine Serum AlbuminIBA 11/2016
1	Perchloric AcidIBA 11/2016
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 08/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	CateninsIBA 11/2014
1	Superoxide Dismutase-1IBA 06/2014
1	GlucocorticoidsIBA 06/2014
1	E-SelectinIBA 04/2014
1	IntegrinsIBA 04/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 04/2014
1	AcidsIBA 11/2013
1	Lymphotoxin-alpha (Lymphotoxin)IBA 11/2013
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2013

Therapy/Procedure

16	Therapeutics 01/2022 - 06/2004
4	Radiotherapy 01/2021 - 03/2013
2	Intravenous Administration 01/2022 - 01/2015
2	Immunotherapy 01/2018 - 03/2013
1	Intravenous Injections 01/2022
1	Image-Guided Radiotherapy 01/2021
1	Radioimmunotherapy 01/2021
1	Cannula 07/2017
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2014